Thermo Fisher Scientific to Present at Bernstein 39th Annual Strategic Decisions Conference on May 31st, 2023 Medical Device Investing
Medtronic Extravascular ICD global clinical trial results reinforce device safety and effectiveness Medical Device Investing
Medtronic Designated as a "3+" Company in the 50/50 Women on Boards Gender Diversity Directory Medical Device Investing
Thermo Fisher Scientific Announces FDA Clearance of Breakthrough Immunoassays to Aid in the Risk Assessment of Preeclampsia Medical Device Investing
New Clinical Study Suggests the Use of OraPharma's ARESTIN Microspheres, 1mg May Decrease Certain Pathogens in Adults with Periodontitis Pharmaceutical Investing
U.S. District Court Upholds Final Judgment for XIFAXAN 550 mg That Prevents FDA Approval of Norwich's Abbreviated New Drug Application Until 2029 Pharmaceutical Investing
Thermo Fisher Scientific Releases 2022 Corporate Social Responsibility Report Medical Device Investing
Medtronic AccuRhythm AI technology receives 2023 MedTech Breakthrough Award as Best New Monitoring Solution Medical Device Investing
Beckman Coulter Unveils Next Generation Immunoassay Analyzer Enabling Elite Laboratory Performance with No Daily Maintenance Medical Device Investing
